Matthew H. Kulke M.D.
Medical Advisory Board
Dr. Matthew Kulke joined the staff of Dana-Farber Cancer Institute in 1997 and is currently an Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. He received an M.D. from the University of California, San Francisco School of Medicine in 1992. He subsequently completed an internship and residency in internal medicine at Brigham and Women's Hospital, a fellowship in medical oncology at Dana-Farber, and received a masters degree in medical science from Harvard Medical School.
Dr. Kulke has led numerous clinical and translational studies in patients with gastrointestinal malignancies and neuroendocrine tumors. He has served as study chair for a national study of pancreatic cancer therapies performed by the Cancer and Leukemia group B and funded by the National Cancer Institute. His current efforts have focused on clinical and translational research in carcinoid and pancreatic neuroendocrine tumors. Dr. Kulke is the recipient of the George Canellos Award for Clinical Investigation and the Ruth Brufsky Award for Pancreatic Cancer Research. He serves on the advisory board for the European Neuroendocrine Tumor Society, the executive committee of the North American Neuroendocrine Tumor Society, and is chair of the Neuroendocrine Tumor Task force for the National Cancer Institute.
Visit Dr. Kulke's Dana-Farber bio page →